TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27173813

Group type: EXPERIMENTAL
Intervention: Sipjeondaebo-tang (3 g, 3 times a day for 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (3 times a day for 4 weeks)
Number of subjects: 40
Study: 24987061

Group type: EXPERIMENTAL
Intervention: Cetuximab (in combination with CAPOX)
Number of subjects: 105

Group type: COMPARATOR
Intervention: CAPOX (without cetuximab)
Number of subjects: 105
Study: 23342566

Group type: EXPERIMENTAL
Intervention: 1.23% APF gel for 1 minute
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1.23% APF gel for 4 minutes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1% TiF4 solution for 1 minute
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 15
Study: 20518267

Group type: EXPERIMENTAL
Intervention: Gynemesh Prolift anterior kit
Number of subjects: 35

Group type: COMPARATOR
Intervention: Individualized size of Gynemesh
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups (Gynemesh Prolift and individualized Gynemesh)
Number of subjects: 35
Study: 18156640

Group type: EXPERIMENTAL
Intervention: Olanzapine, risperidone, and typical antipsychotics
Number of subjects: 443
Study: 15902862

Group type: EXPERIMENTAL
Intervention: CPM from 0 degrees to 40 degrees, increased by 10 degrees per day
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: CPM from 90 degrees to 50 degrees (early flexion), progressed into full extension over 3 days
Number of subjects: 147

Group type: COMPARATOR
Intervention: No CPM (control group)
Number of subjects: 147
Study: 12865605

Group type: EXPERIMENTAL
Intervention: 500 mg of citicoline twice per day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10225070

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with buprenorphine 0.15 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lumbar epidural analgesia (LEA) with buprenorphine 0.15 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (TEA and LEA)
Number of subjects: 40
Study: 8724116

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Diet + Exercise
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control
Number of subjects: 219
Study: 1909239

Group type: EXPERIMENTAL
Intervention: Loreclezole (targeted plasma level of 1-2 mg/l)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 6346912

Group type: EXPERIMENTAL
Intervention: Prophylactic injury prevention program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 180
Study: 30592368

Group type: EXPERIMENTAL
Intervention: Biphasic calcium sulfate/hydroxyapatite (BCS/HA)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bovine derived xenograft (BDX)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No grafting (Control)
Number of subjects: 33
Study: 28381307

Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs after ICH
Number of subjects: 633

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 633
Study: 26875540

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg b.i.d.
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg b.i.d.
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tofacitinib (both doses)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Safety assessment
Number of subjects: 99
Study: 24107831

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 5 mg/mL, 45 mL
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 7.5 mg/mL, 30 mL
Number of subjects: 69

Group type: COMPARATOR
Intervention: Levobupivacaine 7.5 mg/mL mixed with 0.9% NaCl, 30 mL
Number of subjects: 69
Study: 21705084

Group type: EXPERIMENTAL
Intervention: IOP adjusted for CCT using various correction formulae
Number of subjects: 1433

Group type: COMPARATOR
Intervention: Original prediction model without IOP adjustment for CCT
Number of subjects: 1433

Group type: EXPERIMENTAL
Intervention: Baseline IOP (adjusted for CCT or not)
Number of subjects: 1433

Group type: EXPERIMENTAL
Intervention: CCT (with IOP adjusted for CCT)
Number of subjects: 1433
Study: 19605409

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 1734
Study: 17619914

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcutaneous electric nerve stimulation
Number of subjects: 0
Study: 15094142

Group type: EXPERIMENTAL
Intervention: ACL reconstruction surgery using the bone‐patellar tendon‐bone technique
Number of subjects: 25
Study: 11575416

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg kg(‐1) to a maximum of 25 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Ondansetron 100 microg kg(‐1) to a maximum of 4 mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 9681663

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine
Number of subjects: 17
Study: 8121979

Group type: EXPERIMENTAL
Intervention: Guided imagery group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Relaxation group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Guided imagery and relaxation groups
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Follow-up investigation day in study 2
Number of subjects: 30
Study: 2686409

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg twice daily for 14 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ampicillin 500 mg four times a day for 14 days
Number of subjects: 22
Study: 1067409

Group type: EXPERIMENTAL
Intervention: Antimicrobial mouthrinse containing cetylpyridinium chloride and domiphen bromide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control rinse (flavored water)
Number of subjects: 0
Study: 28801309

Group type: EXPERIMENTAL
Intervention: Cold-pressed turnip rapeseed oil (CPTRO) 35 mL for 6-8 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Butter 37.5 g for 6-8 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: CPTRO
Number of subjects: 37
Study: 27421075

Group type: EXPERIMENTAL
Intervention: information + action control text messages
Number of subjects: 121

Group type: COMPARATOR
Intervention: information only
Number of subjects: 121
Study: 24398758

Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m² for 21 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m² for 21 days)
Number of subjects: 0
Study: 22540638

Group type: EXPERIMENTAL
Intervention: Brief online intervention (routine practice)
Number of subjects: 15300

Group type: EXPERIMENTAL
Intervention: Brief assessment and feedback (routine practice)
Number of subjects: 15300

Group type: EXPERIMENTAL
Intervention: Brief assessment only
Number of subjects: 15300

Group type: COMPARATOR
Intervention: No contact control group
Number of subjects: 15300
Study: 20178093

Group type: EXPERIMENTAL
Intervention: Cannabis extract (20 mg THC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diazepam (5 mg)
Number of subjects: 16
Study: 18289159

Group type: EXPERIMENTAL
Intervention: Treatment with anthelmintic drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (untreated or placebo)
Number of subjects: 0
Study: 16816758

Group type: EXPERIMENTAL
Intervention: 12-minute psycho-educational video
Number of subjects: 126

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 126
Study: 14639535

Group type: EXPERIMENTAL
Intervention: Emtricitabine (FTC) 200 mg once daily
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Emtricitabine (FTC) 25 mg once daily
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Emtricitabine (FTC) 100 mg once daily
Number of subjects: 82

Group type: COMPARATOR
Intervention: Lamivudine (3TC) 150 mg 2 times/day
Number of subjects: 82
Study: 10826333

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Geritamine
Number of subjects: 86
Study: 8963946

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1984101

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Trimipramine
Number of subjects: 6
Study: 6230892

Group type: EXPERIMENTAL
Intervention: Zimeldine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31470260

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (LFD)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 55
Study: 29902217

Group type: EXPERIMENTAL
Intervention: Female + male group intervention arm
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: Female only group intervention arm
Number of subjects: 2670

Group type: COMPARATOR
Intervention: Control group (no groups)
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: Female group intervention arm
Number of subjects: 2670
Study: 27211522

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone 20 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone 20 mg plus naltrexone 2.4 mg (simulated crushed ALO-02)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride for injection)
Number of subjects: 33
Study: 24776325

Group type: EXPERIMENTAL
Intervention: Aerobic training program (16 weeks, 50%-60% Vo2peak, 3 times per week)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (sedentary)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Aerobic training program
Number of subjects: 46
Study: 23594808

Group type: EXPERIMENTAL
Intervention: Conventional polyethylene (group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Highly crosslinked polyethylene (group B)
Number of subjects: 28
Study: 20170502

Group type: EXPERIMENTAL
Intervention: Intervention (health promotion curriculum and policies in troop meetings)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (standard-care)
Number of subjects: 76
Study: 17414980

Group type: EXPERIMENTAL
Intervention: Ketorolac (30 mg intraoperative dose)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (no Ketorolac)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 16298922

Group type: EXPERIMENTAL
Intervention: Health Education Programme 'Discovering New Ways'
Number of subjects: 229

Group type: COMPARATOR
Intervention: Individual Programme
Number of subjects: 229
Study: 11865837

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PXF) 400 mg three times daily
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 10219067

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 34
Study: 7776987

Group type: EXPERIMENTAL
Intervention: 240 ml of lactose-hydrolyzed milk containing 2 percent fat
Number of subjects: 30

Group type: COMPARATOR
Intervention: 240 ml of milk containing 2 percent fat and sweetened with aspartame
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lactose-malabsorption group
Number of subjects: 30
Study: 2137976

Group type: EXPERIMENTAL
Intervention: Nafarelin, 200 micrograms twice daily
Number of subjects: 194

Group type: COMPARATOR
Intervention: Danazol, 200 mg twice daily
Number of subjects: 194
Study: 7401172

Group type: EXPERIMENTAL
Intervention: School-based smoking prevention program
Number of subjects: 1526

Group type: EXPERIMENTAL
Intervention: Curriculum elements emphasizing immediate social consequences of smoking
Number of subjects: 1526

Group type: EXPERIMENTAL
Intervention: Personalization of course materials with peer role models and active role playing
Number of subjects: 1526

Group type: EXPERIMENTAL
Intervention: Thiocyanate analysis of saliva samples
Number of subjects: 1526
Study: 30940558

Group type: EXPERIMENTAL
Intervention: Immediate delivery
Number of subjects: 704

Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 704
Study: 28807395

Group type: EXPERIMENTAL
Intervention: Individual embryo transfers (iETs) in the experimental group
Number of subjects: 499

Group type: COMPARATOR
Intervention: Frozen-thawed embryo transfers in the control group
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Pinopode scoring >85
Number of subjects: 499

Group type: COMPARATOR
Intervention: Pinopode scoring ≤85
Number of subjects: 499
Study: 25863797

Group type: EXPERIMENTAL
Intervention: Daily maximum respiratory rate (maxRR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Daily median respiratory rate (medRR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Daily minimum respiratory rate (minRR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Standard deviation of median respiratory rate (medRR)
Number of subjects: 120
Study: 23261207

Group type: EXPERIMENTAL
Intervention: PHAROS Vitesse neurovascular balloon-expandable stent system plus medical therapy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 112
Study: 20868456

Group type: COMPARATOR
Intervention: Southern regular implants and standard ball attachments (control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Southern 8-mm-wide implants and large ball attachments
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Neoss regular implants and Locator attachments
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Southern 8-mm-wide implants and large ball attachments and Neoss regular implants and Locator attachments
Number of subjects: 36
Study: 19615989

Group type: EXPERIMENTAL
Intervention: Semi-quantitative procalcitonin measurement (PCT-Q)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Quantitative procalcitonin measurement (Kryptor)
Number of subjects: 359
Study: 16705849

Group type: EXPERIMENTAL
Intervention: Acupuncture plus SASP and MTX
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Composite sulfur (tablet) moxibustion plus SASP and MTX
Number of subjects: 90

Group type: COMPARATOR
Intervention: SASP and MTX
Number of subjects: 90
Study: 15568609

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11281583

Group type: EXPERIMENTAL
Intervention: 0.2 mg/ml MMC applied for 5 minutes
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 0.5 mg/ml MMC applied for 5 minutes
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard EXT-DCR procedure (Control group)
Number of subjects: 46
Study: 9207749

Group type: EXPERIMENTAL
Intervention: BCG 0.1 mg + 6 x 10(8) KML
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: BCG 0.1 mg + 5 x 10(7) KML
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: BCG 0.1 mg + 5 x 10(6) KML
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: BCG 0.05 mg + 6 x 10(8) KML
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: BCG 0.05 mg + 5 x 10(7) KML
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: BCG 0.01 mg + 5 x 10(7) KML
Number of subjects: 997

Group type: COMPARATOR
Intervention: BCG 0.1 mg
Number of subjects: 997
Study: 8491164

Group type: EXPERIMENTAL
Intervention: Test snack with uncooked cornstarch (complex carbohydrates)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard evening snack (control)
Number of subjects: 9
Study: 2908765

Group type: EXPERIMENTAL
Intervention: Lidamidine (20 mg p.o.)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg p.o.)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Idazoxan (20 mg p.o.)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Basal conditions (Control)
Number of subjects: 27
Study: 30146435

Group type: EXPERIMENTAL
Intervention: Team-based learning (TBL)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 112
Study: 27399998

Group type: EXPERIMENTAL
Intervention: Phenazopyridine
Number of subjects: 104

Group type: COMPARATOR
Intervention: No medications (Control)
Number of subjects: 104
Study: 25197734

Group type: EXPERIMENTAL
Intervention: 10% triphala mouthrinse
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 120

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 120
Study: 22808713

Group type: EXPERIMENTAL
Intervention: 3-minute rest between sets
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1-minute rest between sets
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Delta CK activity
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Total volume of exercise completed
Number of subjects: 20
Study: 20829244

Group type: EXPERIMENTAL
Intervention: Sativex (nabiximols)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 19122958

Group type: COMPARATOR
Intervention: Cryotherapy (liquid nitrogen)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 80 percent phenol solution
Number of subjects: 60
Study: 17313876

Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation (3-month training period)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no exercise rehabilitation)
Number of subjects: 64
Study: 12831585

Group type: EXPERIMENTAL
Intervention: Coasting for 2 days
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Coasting for 3 days
Number of subjects: 50
Study: 11742702

Group type: EXPERIMENTAL
Intervention: Docetaxel plus cisplatin (DC)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Docetaxel plus gemcitabine (DG)
Number of subjects: 317
Study: 9431279

Group type: EXPERIMENTAL
Intervention: Education program on HIV/AIDS
Number of subjects: 1063

Group type: COMPARATOR
Intervention: Control group (comparison condition)
Number of subjects: 1063
Study: 8214494

Group type: EXPERIMENTAL
Intervention: Intra-arterial regional analgesia with lignocaine 0.5%, 1.5 mg.kg‐1
Number of subjects: 26

Group type: COMPARATOR
Intervention: Intravenous regional analgesia with lignocaine 0.5%, 3.0 mg.kg‐1
Number of subjects: 26
Study: 3440240

Group type: EXPERIMENTAL
Intervention: Radical orchidectomy and chemotherapy for Group I patients
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Orchidectomy, chemotherapy, and radiation therapy for Group II patients
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Treatment for patients with distant metastases at diagnosis
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Overall treatment for all 95 children
Number of subjects: 95

Group type: COMPARATOR
Intervention: Comparison to entire IRS series
Number of subjects: 95
Study: 30032997

Group type: EXPERIMENTAL
Intervention: Nursing home staff (nurses and social workers)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Nursing home clinicians (physicians and other advanced practitioners)
Number of subjects: 302
Study: 28407163

Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 0.03% flurbiprofen
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 0.4% ketorolac
Number of subjects: 88

Group type: COMPARATOR
Intervention: Lubricant (control group)
Number of subjects: 88
Study: 25622243

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1.2 g administered 1 hour before the second tlim trial)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (lactose administered 1 hour before the second tlim trial)
Number of subjects: 20
Study: 23946263

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 0
Study: 21775979

Group type: EXPERIMENTAL
Intervention: Duloxetine (14 days treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 18313592

Group type: EXPERIMENTAL
Intervention: Baseline SF-36 physical summary scores
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Baseline QoL Index summary scores
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Baseline Patient Concerns Checklist summary scores
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: QoL measures examined simultaneously
Number of subjects: 740
Study: 16540949

Group type: EXPERIMENTAL
Intervention: Urinary trypsin inhibitor (5000 units/kg intravenous)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 30
Study: 12656696

Group type: EXPERIMENTAL
Intervention: Omeprazole-based triple therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omeprazole plus placebos
Number of subjects: 0
Study: 10720525

Group type: EXPERIMENTAL
Intervention: Ceftazidime (n=34)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Imipenem (n=34)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (Ceftazidime and Imipenem)
Number of subjects: 68
Study: 7490894

Group type: EXPERIMENTAL
Intervention: Self-administered alfentanil via a patient controlled infusion pump
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group receiving alfentanil infusion titrated by anesthesiologists
Number of subjects: 44
Study: 29186989

Group type: EXPERIMENTAL
Intervention: EPVL plus 0.4 mg oral tamsulosin daily (n=236)
Number of subjects: 672

Group type: COMPARATOR
Intervention: EPVL only (n=214)
Number of subjects: 672

Group type: COMPARATOR
Intervention: 0.4 mg tamsulosin PO qd (n=222)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: All groups (EPVL plus tamsulosin, EPVL only, tamsulosin only)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: EPVL plus tamsulosin
Number of subjects: 672
Study: 28730988

Group type: EXPERIMENTAL
Intervention: Keeled all‐polyethylene glenoid component
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pegged all‐polyethylene glenoid component
Number of subjects: 16